Piyasa kapalı· · GBp · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) CEO John Shaw joined Steve Darling from Proactive to discuss the company's strong first-half performance, highlighted by breakeven adjusted EBITDA, a stronger cash position, and continued revenue growth as demand for its sustainable polymer technologies expands across key markets. Shaw said the company's progress can be measured by three critical metrics moving in the right direction simultaneously: revenue growth, profitability, and cash generation. Achieving breakeven adjusted EBITDA marks an important milestone for Itaconix as it continues to sc
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) says its SLAB gene therapy trial in ageing dogs has hit its primary endpoint. It's now in talks with major animal health companies about a licensing deal. EnergyPathways PLC (AIM:EPP) has appointed Jacobs as engineering and regulatory partner for its MESH energy storage project in the Irish Sea. It's now pushing towards a key Ofgem funding submission. Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) is targeting a doubling of revenue to $30 million in the medium term. Half-year revenue already jumped 72% thanks to strong detergent demand. G
Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0), the AIM-listed maker of plant-based specialty polymers used in household detergents, has reiterated its recently upgraded revenue guidance, unveiling plans to more than double revenues to $30 million in the medium term. The company also said it...
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.